Changing the Diagnostics Paradigm: Oxford NanoLabs’ Next-Generation Analytical System Will Bring the Genetic Revolution to Modern Healthcare

Oxford NanoLabs' nanopore-based platform that offers rapid, early, cost-effective, highly sensitive, and accurate diagnosis at the point-of-care will be discussed by Dr. Spike WIllcocks in the Partnering Showcase of the Molecular Medicine Conference 2/27/07 in San Francisco. Oxford NanoLabs (ONL) currently has in development both a rapid influenza test and a blood-based Alzheimer's diagnostic. ONL's longer-term goal is to achieve $1,000 human-genome sequencing. (PRWeb Feb 21, 2007) Post Comment:Trackback URL: http://www.prweb.com/zingpr.php/Q291cC1TcXVhLUhvcnItSG9yci1NYWduLVplcm8=  Read More »